Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,731.07
(
0.47%
)
US TECH 100
24,161.99
(
0.61%
)
Dow Jones
47,101.02
(
0.33%
)
Brent Oil
100.48
(
2.21%
)
Bitcoin
74,660.15
(
-0.25%
)
News Focus
News Focus
Post# of 257251
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Biowatch

Send PM Follow Ignore
Followers 63
Posts 6884
Boards Moderated 1
Alias Born 10/18/2003

Biowatch

Re: DewDiligence post# 29691

Tuesday, 06/06/2006 6:52:10 PM

Tuesday, June 06, 2006 6:52:10 PM

Post# of 257251
Where does HGSI get albumin for Albuferon?

>>ROCKVILLE, Md., June 6 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI ) today announced an exclusive worldwide licensing agreement with Novartis for the development and commercialization of Albuferon(TM) (albumin-interferon alpha 2b) for chronic hepatitis C and all other uses.<<
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now